2021 Fall Conference | Industry Therapeutic Update from Allergan, an AbbVie company: Two Oral CGRP Antagonists for the Treatment of Migraine: Acute Treatment

Date Saturday 11/06/21

Time 02:00 PM - 02:30 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Industry Therapeutic Update

Director(s) Jaclyn Duvall, MD

Topic(s)

CME Available No CME available

Event Timeline
02:00 PM - 02:30 PM EDT	Speaker	Industry Therapeutic Update from Allergan, an AbbVie company: Two Oral CGRP Antagonists for the Treatment of Migraine: Acute Treatment

Faculty Disclosures
Jaclyn Duvall, MD	Dr. Duvall has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie/Allergan. Dr. Duvall has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbive/Alllergan. Dr. Duvall has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Duvall has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Duvall has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Duvall has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven.

��ɫ����